SavedAdd your journal

Journals / E Journal of Cardiovascular Medicine / 2019 / Cilt: 7 - Sayı: 3

Do We Apply Guidelines During Our Daily Practice in Coronary Revascularization?

Ergun DEMİRSOY
MURAT UĞUR
İBRAHİM DEMİR
Pages
104–108
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Creating a “heart team” and activating it, during the decision-making period is recommended in the guidelines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myocardial revascularization guidelines help cardiologist and cardiovascular surgeons to determine the best treatment option for revascularization of the diseased coronary arteries.
📊
Key Findings & Data:In addition, the importance of patient participation is emphasized in determining the treatment strategy.
💡
Conclusion & Impact:Creating a “heart team” and activating it, during the decision-making period is recommended in the guidelines.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Myocardial revascularization guidelines help cardiologist and cardiovascular surgeons to determine the best treatment option for revascularization of the diseased coronary arteries. However, in daily practice compliance to guidelines are generally insufficient. Cardiologist might prefer ad hoc coronary stent implantation without discussing the patients with the surgeons. Creating a “heart team” and activating it, during the decision-making period is recommended in the guidelines. In addition, the importance of patient participation is emphasized in determining the treatment strategy. In this article we aimed to investigate the compliance of the cardiologist and cardiovascular surgeons to the guidelines, and to determine the factors that interfere with the application in daily practice.

🔖

Cite This Article

DEMİRSOY, E., UĞUR, M., DEMİR, İ. (2019). Do We Apply Guidelines During Our Daily Practice in Coronary Revascularization?. E Journal of Cardiovascular Medicine, Cilt: 7 - Sayı: 3, 104–108. https://ajindex.com/articles/152842

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Yates MT, Soppa GK, Valencia O, et al. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease. J Thorac Cardiovasc Surg 2014;147:606-10.
  2. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;55:87-165.
  3. Ribichini F, Taggart D. Implications of new ESC/EACTS guidelines on myocardial revascularization for patients with multivessel coronary artery disease. Interact Cardiovasc Thorac Surg 2011;12:663-6.
  4. Chandrasekharan DP, Taggart DP. Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. Eur J Cardiothorac Surg 2011;39:912-7.
  5. Hannan EL, Racz MJ, Gold J, et al. Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice? Circulation 2010;121:267-75.
  6. Head SJ, Kaul S, Mack MJ, et al. The rationale for Heart Team decisionmaking for patients with stable, complex coronary artery disease. Eur Heart J 2013;34:2510-8.
  7. Hannan EL, Samadashvili Z, Walford G, et al. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. JACC Cardiovasc Interv 2009;2:350-6.
  8. Hannan EL, Cozzens K, Samadashvili Z, et al. Appropriateness of coronary revascularization for patients without acute coronary syndromes. J Am Coll Cardiol 2012;59:1870-6.
  9. Desai NR, Bradley SM, Parzynski CS, et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA 2015;314:2045-53.
  10. Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with threevessel disease: Final five-year follow-up of the SYNTAX trial. Eur Heart J 2014;35:2821-30.
  11. Holmes DR Jr, Rich JB, Zoghbi WA, et al. The heart team of cardiovascular care. J Am Coll Cardiol 2013;61:903-7.
  12. Mishra PK, Luckraz H, Aktuerk D, et al. How does the ‘Heart Team’ decision get enacted for patients with coronary artery disease? Heart Asia 2014;6:31-3.
  13. Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surge